FQ
EVH icon

First Quadrant’s Evolent Health EVH Stock Holding History

First Quadrant’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$21K Hold
650
– – 0.12% 112
2021
Q4 		$18K Buy
+650
New +$18.6K ﹤0.01% 479
2019
Q1 		– Sell
-370
Closed -$7K – 731
2018
Q4 		$7K Hold
370
– – ﹤0.01% 790
2018
Q3 		$11K Buy
+370
New +$8.83K ﹤0.01% 826

Other funds holding EVH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

First Quadrant's EVH Position: Q1 2022 in Review

First Quadrant held its Evolent Health (EVH) position steady in Q1 2022 at 650 shares worth $21K. The position accounts for 0.12% of the portfolio, ranked #112.

First Quadrant first reported a position in EVH in Q3 2018 and has held it in 4 quarters since. 218 funds tracked by Wall St. Rank hold EVH as of Q1 2022.

  • First Quadrant held 650 shares of Evolent Health worth $21K as of Q1 2022.
  • First Quadrant left its Evolent Health share count unchanged in Q1 2022.
  • Evolent Health made up 0.12% of First Quadrant's portfolio in Q1 2022, its #112 holding.
  • First Quadrant first reported a position in Evolent Health in Q3 2018 and has held it in 4 quarters since.
  • 218 funds tracked by Wall St. Rank held Evolent Health as of Q1 2022.

Based on First Quadrant's 13F filing for Q1 2022, filed 21 Apr 2022.